Tue, Nov 24, 2020
The 52 Week Low is $72.67 set on Mon, Mar 16, 2020.
The 52 Week High is $128.19 set on Mon, Nov 16, 2020.
The All-Time High is $208.88 set on Thu, Jul 23, 2015.
Earnings Per Share
Price To Earnings Ratio
Dividend Payment Date
Alexion Pharmaceuticals trades on the NASDAQ. ALXN's market cap is 26.6 Billion.
Alexion Pharmaceuticals specializes in developing and marketing drugs for rare, life-threatening medical conditions. Its blockbuster product, Soliris, is approved for paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), generalized myasthenia gravis (gMG), and neuromyelitis optica spectrum disorder (NMOSD). Next-generation Ultomiris is approved in PNH and aHUS. Strensiq and Kanuma target ultrarare metabolic diseases. Alexion's pipeline targets rare diseases with high unmet need in hematology, nephrology, metabolic diseases, neurology, cardiology, and other areas.